サマリー

北米の検査キット市場 2023-2027
北米の検査キット市場は、2022年から2027年にかけて-87.7億米ドルの成長が予測され、予測期間中のCAGRは-23.81%で減速すると予測されています。当レポートでは、北米の検査キット市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、コロナウイルス迅速検査キットの採用の増加、コロナウイルス診断キットの迅速な承認、コロナウイルス検査キットの販売を促進するための政府の取り組みによって牽引されています。
Technavioの北米の検査キット市場は以下のようにセグメント化されています：
エンドユーザー別
- 政府機関
- 非政府
タイプ別
- 迅速検査キット
- RT-PCR法
- その他
本調査では、新しいcovid-19検査キットの発売が、今後数年間における北米の検査キット市場の成長を促進する主要な理由の1つであると特定している。また、新しいcovid-19変異体の出現と迅速で正確な検査キットを開発する技術の進歩は、市場の大きな需要につながる。
この調査レポートは北米の検査キット市場を分析・予測し、以下のてこ入れを行った：
- 北米の検査キット市場規模
- 北米の検査キット市場予測
- 北米の検査キット市場産業分析
本レポートでは、北米における検査キット市場の主要ベンダー（Abbott Laboratories、Advaite Inc.、Becton Dickinson and Co.、Biomedomics Inc.、bioMerieux SA、Cellex Inc、Co Diagnostics Inc.、Cue Health Inc.、Danaher Corp.、DiaSorin SpA、F. Hoffmann La Roche Ltd.、Hologic Inc.、Laboratory Corp. of America Holdings、Mammoth Biosciences Inc.、MyBioSource Inc.、QIAGEN NV、Quidelortho Corp.、RayBiotech Life Inc.、Robert Bosch GmbH、SHERLOCK BIOSCIENCES、Talis Biomedical Corp.、Thermo Fisher Scientific Inc.また、北米の検査キット市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/coronavirus-test-kits-market-in-north-america-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary €“ Chart on Market Overview
o Exhibit 02: Executive Summary €“ Data Table on Market Overview
o Exhibit 03: Executive Summary €“ Chart on Country Market Characteristics
o Exhibit 04: Executive Summary €“ Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary €“ Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary €“ Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary €“ Chart on Incremental Growth
o Exhibit 08: Executive Summary €“ Data Table on Incremental Growth
o Exhibit 09: Executive Summary €“ Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on North America: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 18: Five forces analysis - Comparison between 2022 and 2027
o 4.2 Bargaining power of buyers
o Exhibit 19: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
o 4.3 Bargaining power of suppliers
o Exhibit 20: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
o 4.4 Threat of new entrants
o Exhibit 21: Threat of new entrants €“ Impact of key factors in 2022 and 2027
o 4.5 Threat of substitutes
o Exhibit 22: Threat of substitutes €“ Impact of key factors in 2022 and 2027
o 4.6 Threat of rivalry
o Exhibit 23: Threat of rivalry €“ Impact of key factors in 2022 and 2027
o 4.7 Market condition
o Exhibit 24: Chart on Market condition - Five forces 2022 and 2027
• 5 Market Segmentation by End-user
o 5.1 Market segments
o Exhibit 25: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 26: Data Table on End-user - Market share 2022-2027 (%)
o 5.2 Comparison by End-user
o Exhibit 27: Chart on Comparison by End-user
o Exhibit 28: Data Table on Comparison by End-user
o 5.3 Government - Market size and forecast 2022-2027
o Exhibit 29: Chart on Government - Market size and forecast 2022-2027 ($ billion)
o Exhibit 30: Data Table on Government - Market size and forecast 2022-2027 ($ billion)
o Exhibit 31: Chart on Government - Year-over-year growth 2022-2027 (%)
o Exhibit 32: Data Table on Government - Year-over-year growth 2022-2027 (%)
o 5.4 Non-government - Market size and forecast 2022-2027
o Exhibit 33: Chart on Non-government - Market size and forecast 2022-2027 ($ billion)
o Exhibit 34: Data Table on Non-government - Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Chart on Non-government - Year-over-year growth 2022-2027 (%)
o Exhibit 36: Data Table on Non-government - Year-over-year growth 2022-2027 (%)
o 5.5 Market opportunity by End-user
o Exhibit 37: Market opportunity by End-user ($ billion)
o Exhibit 38: Data Table on Market opportunity by End-user ($ billion)
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 39: Chart on Type - Market share 2022-2027 (%)
o Exhibit 40: Data Table on Type - Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 41: Chart on Comparison by Type
o Exhibit 42: Data Table on Comparison by Type
o 6.3 Rapid test kit - Market size and forecast 2022-2027
o Exhibit 43: Chart on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Data Table on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
o Exhibit 45: Chart on Rapid test kit - Year-over-year growth 2022-2027 (%)
o Exhibit 46: Data Table on Rapid test kit - Year-over-year growth 2022-2027 (%)
o 6.4 RT-PCR - Market size and forecast 2022-2027
o Exhibit 47: Chart on RT-PCR - Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Data Table on RT-PCR - Market size and forecast 2022-2027 ($ billion)
o Exhibit 49: Chart on RT-PCR - Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on RT-PCR - Year-over-year growth 2022-2027 (%)
o 6.5 Others - Market size and forecast 2022-2027
o Exhibit 51: Chart on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 52: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Type
o Exhibit 55: Market opportunity by Type ($ billion)
o Exhibit 56: Data Table on Market opportunity by Type ($ billion)
• 7 Customer Landscape
o 7.1 Customer landscape overview
o Exhibit 57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 8 Geographic Landscape
o 8.1 Geographic segmentation
o Exhibit 58: Chart on Market share By Geographical Landscape - 2022-2027 (%)
o Exhibit 59: Data Table on Market share By Geographical Landscape - 2022-2027 (%)
o 8.2 Geographic comparison
o Exhibit 60: Chart on Geographic comparison
o Exhibit 61: Data Table on Geographic comparison
o 8.3 US - Market size and forecast 2022-2027
o Exhibit 62: Chart on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 63: Data Table on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 64: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2022-2027 (%)
o 8.4 Canada - Market size and forecast 2022-2027
o Exhibit 66: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
o Exhibit 67: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
o Exhibit 68: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 69: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 8.5 Mexico - Market size and forecast 2022-2027
o Exhibit 70: Chart on Mexico - Market size and forecast 2022-2027 ($ billion)
o Exhibit 71: Data Table on Mexico - Market size and forecast 2022-2027 ($ billion)
o Exhibit 72: Chart on Mexico - Year-over-year growth 2022-2027 (%)
o Exhibit 73: Data Table on Mexico - Year-over-year growth 2022-2027 (%)
o 8.6 Market opportunity By Geographical Landscape
o Exhibit 74: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 75: Data Table on Market opportunity By Geographical Landscape ($ billion)
• 9 Drivers, Challenges, and Trends
o 9.1 Market drivers
o 9.2 Market challenges
o 9.3 Impact of drivers and challenges
o Exhibit 76: Impact of drivers and challenges in 2022 and 2027
o 9.4 Market trends
• 10 Vendor Landscape
o 10.1 Overview
o 10.2 Vendor landscape
o Exhibit 77: Overview on Criticality of inputs and Factors of differentiation
o 10.3 Landscape disruption
o Exhibit 78: Overview on factors of disruption
o 10.4 Industry risks
o Exhibit 79: Impact of key risks on business
• 11 Vendor Analysis
o 11.1 Vendors covered
o Exhibit 80: Vendors covered
o 11.2 Market positioning of vendors
o Exhibit 81: Matrix on vendor position and classification
o 11.3 Abbott Laboratories
o Exhibit 82: Abbott Laboratories - Overview
o Exhibit 83: Abbott Laboratories - Business segments
o Exhibit 84: Abbott Laboratories - Key news
o Exhibit 85: Abbott Laboratories - Key offerings
o Exhibit 86: Abbott Laboratories - Segment focus
o 11.4 Advaite Inc.
o Exhibit 87: Advaite Inc. - Overview
o Exhibit 88: Advaite Inc. - Product / Service
o Exhibit 89: Advaite Inc. - Key offerings
o 11.5 Becton Dickinson and Co.
o Exhibit 90: Becton Dickinson and Co. - Overview
o Exhibit 91: Becton Dickinson and Co. - Business segments
o Exhibit 92: Becton Dickinson and Co. - Key news
o Exhibit 93: Becton Dickinson and Co. - Key offerings
o Exhibit 94: Becton Dickinson and Co. - Segment focus
o 11.6 Biomedomics Inc.
o Exhibit 95: Biomedomics Inc. - Overview
o Exhibit 96: Biomedomics Inc. - Product / Service
o Exhibit 97: Biomedomics Inc. - Key offerings
o 11.7 bioMerieux SA
o Exhibit 98: bioMerieux SA - Overview
o Exhibit 99: bioMerieux SA - Product / Service
o Exhibit 100: bioMerieux SA - Key news
o Exhibit 101: bioMerieux SA - Key offerings
o 11.8 Cellex Inc.
o Exhibit 102: Cellex Inc. - Overview
o Exhibit 103: Cellex Inc. - Product / Service
o Exhibit 104: Cellex Inc. - Key offerings
o 11.9 Co Diagnostics Inc.
o Exhibit 105: Co Diagnostics Inc. - Overview
o Exhibit 106: Co Diagnostics Inc. - Product / Service
o Exhibit 107: Co Diagnostics Inc. - Key news
o Exhibit 108: Co Diagnostics Inc. - Key offerings
o 11.10 Cue Health Inc.
o Exhibit 109: Cue Health Inc. - Overview
o Exhibit 110: Cue Health Inc. - Product / Service
o Exhibit 111: Cue Health Inc. - Key offerings
o 11.11 Danaher Corp.
o Exhibit 112: Danaher Corp. - Overview
o Exhibit 113: Danaher Corp. - Business segments
o Exhibit 114: Danaher Corp. - Key news
o Exhibit 115: Danaher Corp. - Key offerings
o Exhibit 116: Danaher Corp. - Segment focus
o 11.12 DiaSorin SpA
o Exhibit 117: DiaSorin SpA - Overview
o Exhibit 118: DiaSorin SpA - Business segments
o Exhibit 119: DiaSorin SpA - Key news
o Exhibit 120: DiaSorin SpA - Key offerings
o Exhibit 121: DiaSorin SpA - Segment focus
o 11.13 F. Hoffmann La Roche Ltd.
o Exhibit 122: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 123: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 124: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 125: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 126: F. Hoffmann La Roche Ltd. - Segment focus
o 11.14 Hologic Inc.
o Exhibit 127: Hologic Inc. - Overview
o Exhibit 128: Hologic Inc. - Business segments
o Exhibit 129: Hologic Inc. - Key news
o Exhibit 130: Hologic Inc. - Key offerings
o Exhibit 131: Hologic Inc. - Segment focus
o 11.15 Laboratory Corp. of America Holdings
o Exhibit 132: Laboratory Corp. of America Holdings - Overview
o Exhibit 133: Laboratory Corp. of America Holdings - Business segments
o Exhibit 134: Laboratory Corp. of America Holdings - Key news
o Exhibit 135: Laboratory Corp. of America Holdings - Key offerings
o Exhibit 136: Laboratory Corp. of America Holdings - Segment focus
o 11.16 QIAGEN NV
o Exhibit 137: QIAGEN NV - Overview
o Exhibit 138: QIAGEN NV - Product / Service
o Exhibit 139: QIAGEN NV - Key news
o Exhibit 140: QIAGEN NV - Key offerings
o 11.17 Thermo Fisher Scientific Inc.
o Exhibit 141: Thermo Fisher Scientific Inc. - Overview
o Exhibit 142: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 143: Thermo Fisher Scientific Inc. - Key news
o Exhibit 144: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 145: Thermo Fisher Scientific Inc. - Segment focus
• 12 Appendix
o 12.1 Scope of the report
o 12.2 Inclusions and exclusions checklist
o Exhibit 146: Inclusions checklist
o Exhibit 147: Exclusions checklist
o 12.3 Currency conversion rates for US$
o Exhibit 148: Currency conversion rates for US$
o 12.4 Research methodology
o Exhibit 149: Research methodology
o Exhibit 150: Validation techniques employed for market sizing
o Exhibit 151: Information sources
o 12.5 List of abbreviations
o Exhibit 152: List of abbreviations


Exhibits:
Exhibits1: Executive Summary €“ Chart on Market Overview
Exhibits2: Executive Summary €“ Data Table on Market Overview
Exhibits3: Executive Summary €“ Chart on Country Market Characteristics
Exhibits4: Executive Summary €“ Chart on Market By Geographical Landscape
Exhibits5: Executive Summary €“ Chart on Market Segmentation by End-user
Exhibits6: Executive Summary €“ Chart on Market Segmentation by Type
Exhibits7: Executive Summary €“ Chart on Incremental Growth
Exhibits8: Executive Summary €“ Data Table on Incremental Growth
Exhibits9: Executive Summary €“ Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on North America: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
Exhibits18: Five forces analysis - Comparison between 2022 and 2027
Exhibits19: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
Exhibits20: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
Exhibits21: Threat of new entrants €“ Impact of key factors in 2022 and 2027
Exhibits22: Threat of substitutes €“ Impact of key factors in 2022 and 2027
Exhibits23: Threat of rivalry €“ Impact of key factors in 2022 and 2027
Exhibits24: Chart on Market condition - Five forces 2022 and 2027
Exhibits25: Chart on End-user - Market share 2022-2027 (%)
Exhibits26: Data Table on End-user - Market share 2022-2027 (%)
Exhibits27: Chart on Comparison by End-user
Exhibits28: Data Table on Comparison by End-user
Exhibits29: Chart on Government - Market size and forecast 2022-2027 ($ billion)
Exhibits30: Data Table on Government - Market size and forecast 2022-2027 ($ billion)
Exhibits31: Chart on Government - Year-over-year growth 2022-2027 (%)
Exhibits32: Data Table on Government - Year-over-year growth 2022-2027 (%)
Exhibits33: Chart on Non-government - Market size and forecast 2022-2027 ($ billion)
Exhibits34: Data Table on Non-government - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Chart on Non-government - Year-over-year growth 2022-2027 (%)
Exhibits36: Data Table on Non-government - Year-over-year growth 2022-2027 (%)
Exhibits37: Market opportunity by End-user ($ billion)
Exhibits38: Data Table on Market opportunity by End-user ($ billion)
Exhibits39: Chart on Type - Market share 2022-2027 (%)
Exhibits40: Data Table on Type - Market share 2022-2027 (%)
Exhibits41: Chart on Comparison by Type
Exhibits42: Data Table on Comparison by Type
Exhibits43: Chart on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Data Table on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
Exhibits45: Chart on Rapid test kit - Year-over-year growth 2022-2027 (%)
Exhibits46: Data Table on Rapid test kit - Year-over-year growth 2022-2027 (%)
Exhibits47: Chart on RT-PCR - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Data Table on RT-PCR - Market size and forecast 2022-2027 ($ billion)
Exhibits49: Chart on RT-PCR - Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on RT-PCR - Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits52: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits53: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Type ($ billion)
Exhibits56: Data Table on Market opportunity by Type ($ billion)
Exhibits57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits58: Chart on Market share By Geographical Landscape - 2022-2027 (%)
Exhibits59: Data Table on Market share By Geographical Landscape - 2022-2027 (%)
Exhibits60: Chart on Geographic comparison
Exhibits61: Data Table on Geographic comparison
Exhibits62: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits63: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits64: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits65: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits66: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits67: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits68: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits69: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits70: Chart on Mexico - Market size and forecast 2022-2027 ($ billion)
Exhibits71: Data Table on Mexico - Market size and forecast 2022-2027 ($ billion)
Exhibits72: Chart on Mexico - Year-over-year growth 2022-2027 (%)
Exhibits73: Data Table on Mexico - Year-over-year growth 2022-2027 (%)
Exhibits74: Market opportunity By Geographical Landscape ($ billion)
Exhibits75: Data Table on Market opportunity By Geographical Landscape ($ billion)
Exhibits76: Impact of drivers and challenges in 2022 and 2027
Exhibits77: Overview on Criticality of inputs and Factors of differentiation
Exhibits78: Overview on factors of disruption
Exhibits79: Impact of key risks on business
Exhibits80: Vendors covered
Exhibits81: Matrix on vendor position and classification
Exhibits82: Abbott Laboratories - Overview
Exhibits83: Abbott Laboratories - Business segments
Exhibits84: Abbott Laboratories - Key news
Exhibits85: Abbott Laboratories - Key offerings
Exhibits86: Abbott Laboratories - Segment focus
Exhibits87: Advaite Inc. - Overview
Exhibits88: Advaite Inc. - Product / Service
Exhibits89: Advaite Inc. - Key offerings
Exhibits90: Becton Dickinson and Co. - Overview
Exhibits91: Becton Dickinson and Co. - Business segments
Exhibits92: Becton Dickinson and Co. - Key news
Exhibits93: Becton Dickinson and Co. - Key offerings
Exhibits94: Becton Dickinson and Co. - Segment focus
Exhibits95: Biomedomics Inc. - Overview
Exhibits96: Biomedomics Inc. - Product / Service
Exhibits97: Biomedomics Inc. - Key offerings
Exhibits98: bioMerieux SA - Overview
Exhibits99: bioMerieux SA - Product / Service
Exhibits100: bioMerieux SA - Key news
Exhibits101: bioMerieux SA - Key offerings
Exhibits102: Cellex Inc. - Overview
Exhibits103: Cellex Inc. - Product / Service
Exhibits104: Cellex Inc. - Key offerings
Exhibits105: Co Diagnostics Inc. - Overview
Exhibits106: Co Diagnostics Inc. - Product / Service
Exhibits107: Co Diagnostics Inc. - Key news
Exhibits108: Co Diagnostics Inc. - Key offerings
Exhibits109: Cue Health Inc. - Overview
Exhibits110: Cue Health Inc. - Product / Service
Exhibits111: Cue Health Inc. - Key offerings
Exhibits112: Danaher Corp. - Overview
Exhibits113: Danaher Corp. - Business segments
Exhibits114: Danaher Corp. - Key news
Exhibits115: Danaher Corp. - Key offerings
Exhibits116: Danaher Corp. - Segment focus
Exhibits117: DiaSorin SpA - Overview
Exhibits118: DiaSorin SpA - Business segments
Exhibits119: DiaSorin SpA - Key news
Exhibits120: DiaSorin SpA - Key offerings
Exhibits121: DiaSorin SpA - Segment focus
Exhibits122: F. Hoffmann La Roche Ltd. - Overview
Exhibits123: F. Hoffmann La Roche Ltd. - Business segments
Exhibits124: F. Hoffmann La Roche Ltd. - Key news
Exhibits125: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits126: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits127: Hologic Inc. - Overview
Exhibits128: Hologic Inc. - Business segments
Exhibits129: Hologic Inc. - Key news
Exhibits130: Hologic Inc. - Key offerings
Exhibits131: Hologic Inc. - Segment focus
Exhibits132: Laboratory Corp. of America Holdings - Overview
Exhibits133: Laboratory Corp. of America Holdings - Business segments
Exhibits134: Laboratory Corp. of America Holdings - Key news
Exhibits135: Laboratory Corp. of America Holdings - Key offerings
Exhibits136: Laboratory Corp. of America Holdings - Segment focus
Exhibits137: QIAGEN NV - Overview
Exhibits138: QIAGEN NV - Product / Service
Exhibits139: QIAGEN NV - Key news
Exhibits140: QIAGEN NV - Key offerings
Exhibits141: Thermo Fisher Scientific Inc. - Overview
Exhibits142: Thermo Fisher Scientific Inc. - Business segments
Exhibits143: Thermo Fisher Scientific Inc. - Key news
Exhibits144: Thermo Fisher Scientific Inc. - Key offerings
Exhibits145: Thermo Fisher Scientific Inc. - Segment focus
Exhibits146: Inclusions checklist
Exhibits147: Exclusions checklist
Exhibits148: Currency conversion rates for US$
Exhibits149: Research methodology
Exhibits150: Validation techniques employed for market sizing
Exhibits151: Information sources
Exhibits152: List of abbreviations